aTyr Pharma Inc (NASDAQ:LIFE)
| 3.99 Delayed Data As of 3:58pm ET |  +0.29 / +7.84%Today’s Change | 2.93 Today|||52-Week Range 8.33 | +2.84% Year-to-Date |
Latest LIFE News | Press Releases
| Atyr Pharma (LIFE) Reports Q1 Loss, Lags Revenue Estimates May 13 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.70 |
| Today’s open | 3.85 |
| Day’s range | 3.84 - 4.04 |
| Volume | 7,596 |
| Average volume (3 months) | 1,132,847 |
| Market cap | $58.6M |
Data as of 3:58pm ET, 05/18/2021
Growth & Valuation
| Earnings growth (last year) | +74.82% |
| Earnings growth (this year) | -3.67% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +2,377.49% |
| P/E ratio | NM |
| Price/Sales | 3.40 |
| Price/Book | 1.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DAREDare Bioscience Inc | +0.01 | +0.74% |
| CYCCCyclacel Pharmaceuti... | +0.56 | +7.90% |
| ACHVAchieve Life Science... | +0.55 | +5.78% |
| BBIBrickell Biotech Inc | +0.01 | +1.15% |
Data as of 3:59pm ET, 05/18/2021
Financials
| Next reporting date | August 18, 2021 |
| EPS forecast (this quarter) | -$0.50 |
| Annual revenue (last year) | $10.5M |
| Annual profit (last year) | -$16.2M |
| Net profit margin | -155.18% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
